These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 15293526

  • 21. Serum leptin levels and malnutrition in patients with chronic renal failure.
    Kayardi M, Icagasioglu S, Yilmaz A, Candan F.
    Saudi Med J; 2006 Apr; 27(4):477-81. PubMed ID: 16598323
    [Abstract] [Full Text] [Related]

  • 22. [Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
    Shidara K, Inaba M, Kumeda Y, Imanishi Y, Tahara H, Ishimura E, Nishizawa Y, Yamakawa T, Okuno S.
    Clin Calcium; 2005 Sep; 15 Suppl 1():102-4; discussion 104-5. PubMed ID: 16279018
    [Abstract] [Full Text] [Related]

  • 23. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R.
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [Abstract] [Full Text] [Related]

  • 24. Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
    Tsuchida T, Ishimura E, Hirowatari K, Matsumoto N, Imanishi Y, Jono S, Miki T, Inaba M, Nishizawa Y.
    Nephron Clin Pract; 2006 Oct; 102(3-4):c108-14. PubMed ID: 16286785
    [Abstract] [Full Text] [Related]

  • 25. Correlates of habitual physical activity in chronic haemodialysis patients.
    Zamojska S, Szklarek M, Niewodniczy M, Nowicki M.
    Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
    [Abstract] [Full Text] [Related]

  • 26. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?
    Coen G, Manni M, Mantella D, Pierantozzi A, Balducci A, Condò S, DiGiulio S, Yancovic L, Lippi B, Manca S, Morosetti M, Pellegrino L, Simonetti G, Gallucci MT, Splendiani G.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083
    [Abstract] [Full Text] [Related]

  • 27. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
    Zofkova I, Hill M.
    Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
    [Abstract] [Full Text] [Related]

  • 28. Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.
    Alvarez L, Torregrosa JV, Peris P, Monegal A, Bedini JL, Martinez De Osaba MJ, Filella X, Martin G, Ricos C, Oppenheimer F, Ballesta AM.
    J Bone Miner Metab; 2004 Sep; 22(3):254-9. PubMed ID: 15108068
    [Abstract] [Full Text] [Related]

  • 29. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G, Charra B, Chazot C.
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [Abstract] [Full Text] [Related]

  • 30. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
    Al-Harithy RN.
    Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
    [Abstract] [Full Text] [Related]

  • 31. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 32. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 33. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
    Nasri H, Kheiri S.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
    [Abstract] [Full Text] [Related]

  • 34. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.
    Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH.
    Kidney Int; 2001 Oct; 60(4):1460-8. PubMed ID: 11576360
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Leptin, leptin soluble receptor and coronary atherosclerosis.
    Hoefle G, Saely CH, Risch L, Rein P, Koch L, Schmid F, Aczél S, Marte T, Langer P, Drexel H.
    Eur J Clin Invest; 2007 Aug; 37(8):629-36. PubMed ID: 17635573
    [Abstract] [Full Text] [Related]

  • 37. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW, Galley SA, Vaughan MR, Patterson-Buckendahl P, Demers LM, Vance JL, McGee ME.
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [Abstract] [Full Text] [Related]

  • 38. Serum leptin level in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling.
    Shabat S, Nyska M, Eintacht S, Lis M, Bogomolni A, Berner Y, Kestanbaum-Shainkin R.
    Arch Gerontol Geriatr; 2009 May; 48(2):250-3. PubMed ID: 18359113
    [Abstract] [Full Text] [Related]

  • 39. Influence of the hepatocellular damage on the clinical usefulness of biochemical markers of bone metabolism and parathormon in haemodialysed patients.
    Jaroszyński AJ, Ksiazek A, Załuska W.
    Med Sci Monit; 2002 Sep; 8(9):CR652-6. PubMed ID: 12218948
    [Abstract] [Full Text] [Related]

  • 40. Interrelationship between bone turnover markers, calciotropic hormones and leptin in obese Saudi children.
    Saber LM, Mahran HN, Baghdadi HH, Al Hawsawi ZM.
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4332-43. PubMed ID: 26636521
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.